Related references
Note: Only part of the references are listed.Macrophages: shapes and functions
Uwe Lendeckel et al.
CHEMTEXTS (2022)
Molecular Pathways of Interferon-Stimulated Gene 15: Implications in Cancer
Angeles C. Tecalco-Cruz
CURRENT PROTEIN & PEPTIDE SCIENCE (2021)
Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection
Deeksha Munnur et al.
NATURE IMMUNOLOGY (2021)
ISGylation in Innate Antiviral Immunity and Pathogen Defense Responses: A Review
Mengdi Zhang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity
GuanQun Liu et al.
NATURE MICROBIOLOGY (2021)
Single-cell analysis reveals divergent responses of human dendritic cells to the MVA vaccine
Marius Doring et al.
SCIENCE SIGNALING (2021)
Enhancement of HIV-1 Env-Specific CD8 T Cell Responses Using Interferon-Stimulated Gene 15 as an Immune Adjuvant
Carmen Elena Gomez et al.
JOURNAL OF VIROLOGY (2021)
Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B
Patricia Perez et al.
VACCINES (2020)
IFN-Stimulated Gene 15 Is an Alarmin that Boosts the CTL Response via an Innate, NK Cell-Dependent Route
Victoria Iglesias-Guimarais et al.
JOURNAL OF IMMUNOLOGY (2020)
Characterization and Noncovalent Inhibition of the Deubiquitinase and delSGylase Activity of SARS-CoV-2 Papain-Like Protease
Brendan T. Freitas et al.
ACS INFECTIOUS DISEASES (2020)
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
Donghyuk Shin et al.
NATURE (2020)
Tumor Cell-Secreted ISG15 Promotes Tumor Cell Migration and Immune Suppression by Inducing the Macrophage M2-Like Phenotype
Ren-Hui Chen et al.
FRONTIERS IN IMMUNOLOGY (2020)
More than Meets the ISG15: Emerging Roles in the DNA Damage Response and Beyond
Zac Sandy et al.
BIOMOLECULES (2020)
Cysteine-Reactive Free ISG15 Generates IL-1β-Producing CD8α+ Dendritic Cells at the Site of Infection
Anna Napolitano et al.
JOURNAL OF IMMUNOLOGY (2018)
ISG15 in antiviral immunity and beyond
Yi-Chieh Perng et al.
NATURE REVIEWS MICROBIOLOGY (2018)
ISG15 in cancer: Beyond ubiquitin-like protein
Hye Gyeong Han et al.
CANCER LETTERS (2018)
ISG15, a Small Molecule with Huge Implications: Regulation of Mitochondrial Homeostasis
Manuel Albert et al.
VIRUSES-BASEL (2018)
Extracellular ISG15 Signals Cytokine Secretion through the LFA-1 Integrin Receptor
Caleb D. Swaim et al.
MOLECULAR CELL (2017)
Development of targeted adjuvants for HIV-1 vaccines
Jun Liu et al.
AIDS RESEARCH AND THERAPY (2017)
ISG15 Is Upregulated in Respiratory Syncytial Virus Infection and Reduces Virus Growth through Protein ISGylation
Ruben Gonzalez-Sanz et al.
JOURNAL OF VIROLOGY (2016)
Influenza B virus non-structural protein 1 counteracts ISG15 antiviral activity by sequestering ISGylated viral proteins
Chen Zhao et al.
NATURE COMMUNICATIONS (2016)
Adjuvants for HIV vaccines
Mangala Rao et al.
CURRENT OPINION IN HIV AND AIDS (2016)
Ubiquitin-like Molecule ISG15 Acts as an Immune Adjuvant to Enhance Antigen-specific CD8 T-cell Tumor Immunity
Daniel O. Villarreal et al.
MOLECULAR THERAPY (2015)
A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART
Carmen Elena Gomez et al.
PLOS ONE (2015)
The Evolution of Poxvirus Vaccines
Lucas Sanchez-Sampedro et al.
VIRUSES-BASEL (2015)
ISG15 counteracts Listeria monocytogenes infection
Lilliana Radoshevich et al.
ELIFE (2015)
Deletion of the Vaccinia Virus N2L Gene Encoding an Inhibitor of IRF3 Improves the Immunogenicity of Modified Vaccinia Virus Ankara Expressing HIV-1 Antigens
Juan Garcia-Arriaza et al.
JOURNAL OF VIROLOGY (2014)
Differential Induction of Apoptosis, Interferon Signaling, and Phagocytosis in Macrophages Infected with a Panel of Attenuated and Nonattenuated Poxviruses
Sandra Royo et al.
JOURNAL OF VIROLOGY (2014)
A Novel Poxvirus-Based Vaccine, MVA-CHIKV, Is Highly Immunogenic and Protects Mice against Chikungunya Infection
Juan Garcia-Arriaza et al.
JOURNAL OF VIROLOGY (2014)
Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
Arwen F. Altenburg et al.
VIRUSES-BASEL (2014)
ISG15 regulates IFN-γ immunity in human mycobacterial disease
Jun-Bao Fan et al.
CELL RESEARCH (2013)
The Antiviral Activities of ISG15
David J. Morales et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
High, Broad, Polyfunctional, and Durable T Cell Immune Responses Induced in Mice by a Novel Hepatitis C Virus (HCV) Vaccine Candidate (MVA-HCV) Based on Modified Vaccinia Virus Ankara Expressing the Nearly Full-Length HCV Genome
Carmen E. Gomez et al.
JOURNAL OF VIROLOGY (2013)
Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways
Juan Garcia-Arriaza et al.
PLOS ONE (2013)
ISG15 Regulates Peritoneal Macrophages Functionality against Viral Infection
Emilio Yangueez et al.
PLOS PATHOGENS (2013)
Mycobacterial Disease and Impaired IFN-γ Immunity in Humans with Inherited ISG15 Deficiency
Dusan Bogunovic et al.
SCIENCE (2012)
A Candidate HIV/AIDS Vaccine (MVA-B) Lacking Vaccinia Virus Gene C6L Enhances Memory HIV-1-Specific T-Cell Responses
Juan Garcia-Arriaza et al.
PLOS ONE (2011)
Herc5 Attenuates Influenza A Virus by Catalyzing ISGylation of Viral NS1 Protein
YuJie Tang et al.
JOURNAL OF IMMUNOLOGY (2010)
Selective Induction of Host Genes by MVA-B, a Candidate Vaccine against HIV/AIDS
Susana Guerra et al.
JOURNAL OF VIROLOGY (2010)
Insertion of Vaccinia Virus C7L Host Range Gene into NYVAC-B Genome Potentiates Immune Responses against HIV-1 Antigens
Jose Luis Najera et al.
PLOS ONE (2010)
Immunogenic Profiling in Mice of a HIV/AIDS Vaccine Candidate (MVA-B) Expressing Four HIV-1 Antigens and Potentiation by Specific Gene Deletions
Juan Garcia-Arriaza et al.
PLOS ONE (2010)
ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells
Chen Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
New horizons in adjuvants for vaccine development
Steven G. Reed et al.
TRENDS IN IMMUNOLOGY (2009)
Construction, characterization, and immunogenicity of a multigene modified vaccinia Ankara (MVA) vaccine based on HIV type 1 subtype C
Wendy A. Burgers et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2008)
ISG15 inhibit Ebola VP40VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity
Atsushi Okumura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Vaccinia virus E3 protein prevents the antiviral action of ISG15
Susana Guerra et al.
PLOS PATHOGENS (2008)
Virus distribution of the attenuated MVA and NYVAC poxvirus strains in mice
Carmen Elena Gomez et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1IIIB Gag-Pol-Nef proteins of clade B
Carmen Elena Gomez et al.
VACCINE (2007)
TLR-ligand stimulated interleukin-23 subunit expression and assembly is regulated differentially in murine plasmacytoid and myeloid dendritic cells
Zoe Waibler et al.
MOLECULAR IMMUNOLOGY (2007)
Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-β
Jiangao Zhu et al.
BLOOD (2007)
Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB/c mice
David C. Tscharke et al.
JOURNAL OF VIROLOGY (2006)
Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene
Jos Luis Najera et al.
JOURNAL OF VIROLOGY (2006)
Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15
A Okumura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Crystal structure of the interferon-induced ubiquitin-like protein ISG15
J Narasimhan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Involvement of UBE1L in ISG15 conjugation during retinoid-induced differentiation of acute promyelocytic leukemia
I Pitha-Rowe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Identification of a ubiquitin family protein as a novel neutrophil chemotactic factor
M Owhashi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3
O Malakhova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector
JC Ramírez et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
